If you’ve been anywhere near an OR lounge, you’ve probably heard more talk about Ozempic face than about sagittal balance lately. GLP-1 receptor agonists like Ozempic are making waves far beyond the endocrinology world. And according to a new study, they might be quietly helping your spine fusion patients, too.
The Big Question
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.

